Subtopic Deep Dive

Ehlers-Danlos Syndrome Collagen Mutations
Research Guide

What is Ehlers-Danlos Syndrome Collagen Mutations?

Ehlers-Danlos Syndrome Collagen Mutations refer to genetic variants in COL3A1, COL5A1, and related genes causing vascular and classical EDS types through protein misfolding and extracellular matrix defects.

Research integrates clinical phenotypes with biophysical modeling of collagen fibril abnormalities. Key papers include Malfait et al. (2017, 1749 citations) on EDS classification and Kuivaniemi and Tromp (2019, 398 citations) on COL3A1 structure. Over 10 major papers from provided lists address mutations and tissue impacts.

Curated Papers

Key Challenges

Why It Matters

Mutations in COL3A1 lead to vascular EDS type IV with arterial rupture risks, as shown in Oderich et al. (2005, 430 citations) 30-year clinical outcomes. Understanding these improves risk stratification for life-threatening events (Malfait et al., 2017). Biophysical models from Corsi et al. (2002, 447 citations) link proteoglycan deficiencies to EDS-like fibril defects, aiding targeted therapies.

Key Research Challenges

Genotype-Phenotype Correlation

Mapping specific COL3A1 mutations to vascular rupture risks remains imprecise. Malfait et al. (2017) classify 13 EDS subtypes but note variable expressivity. Kuivaniemi and Tromp (2019) detail COL3A1 diseases yet lack predictive models.

Collagen Fibril Modeling

Simulating misfolding effects on extracellular matrix is computationally intensive. Corsi et al. (2002) show biglycan deficiency mimics EDS fibril changes. Laurent et al. (2005, 430 citations) link genetic bases to arterial stiffness.

Clinical Risk Stratification

Predicting aortic events from mutations integrates poor with imaging data. Oderich et al. (2005) report EDS IV outcomes but highlight management gaps. Milewicz et al. (2008, 393 citations) focus on smooth muscle dysfunction in aneurysms.

Essential Papers

The revised Ghent nosology for the Marfan syndrome: Table 1

Bart Loeys, Harry C. Dietz, Alan C. Braverman et al. · 2010 · Journal of Medical Genetics · 2.2K citations

The diagnosis of Marfan syndrome (MFS) relies on defined clinical criteria (Ghent nosology), outlined by international expert opinion to facilitate accurate recognition of this genetic aneurysm syn...

The 2017 international classification of the Ehlers–Danlos syndromes

Fransiska Malfait, Clair A. Francomano, Peter H. Byers et al. · 2017 · American Journal of Medical Genetics Part C Seminars in Medical Genetics · 1.7K citations

The Ehlers–Danlos syndromes (EDS) are a clinically and genetically heterogeneous group of heritable connective tissue disorders (HCTDs) characterized by joint hypermobility, skin hyperextensibility...

Hypermobile Ehlers–Danlos syndrome (a.k.a. Ehlers–Danlos syndrome Type III and Ehlers–Danlos syndrome hypermobility type): Clinical description and natural history

Brad T. Tinkle, Marco Castori, Britta Berglund et al. · 2017 · American Journal of Medical Genetics Part C Seminars in Medical Genetics · 454 citations

The hypermobile type of Ehlers–Danlos syndrome (hEDS) is likely the most common hereditary disorder of connective tissue. It has been described largely in those with musculoskeletal complaints incl...

Phenotypic Effects of Biglycan Deficiency Are Linked to Collagen Fibril Abnormalities, Are Synergized by Decorin Deficiency, and Mimic Ehlers-Danlos-Like Changes in Bone and Other Connective Tissues

Alessandro Corsi, Tianshun Xu, Xiao‐Dong Chen et al. · 2002 · Journal of Bone and Mineral Research · 447 citations

Abstract Decorin (dcn) and biglycan (bgn), two members of the family of small leucine-rich proteoglycans (SLRPs), are the predominant proteoglycans expressed in skin and bone, respectively. Targete...

Effects of ascorbic acid on collagen matrix formation and osteoblast differentiation in murine MC3T3-E1 cells

Renny T. Franceschi, Bhanumathi S. Iyer, Yingqi Cui · 1994 · Journal of Bone and Mineral Research · 437 citations

Abstract Treatment of mouse MC3T3-E1 cells with ascorbic acid initiates the formation of a collagenous extracellular matrix and synthesis of several osteoblast-related proteins. We recently showed ...

The spectrum, management and clinical outcome of Ehlers-Danlos syndrome type IV: A 30-year experience

Gustavo S. Oderich, Jean M. Panneton, Thomas C. Bower et al. · 2005 · Journal of Vascular Surgery · 430 citations

Structural and Genetic Bases of Arterial Stiffness

Stéphane Laurent, Pierre Boutouyrie, Patrick Lacolley · 2005 · Hypertension · 430 citations

Arterial stiffness has independent predictive value for cardiovascular events. We review data concerning the heritability of arterial stiffness, and propose an integrated view of the structural and...

Reading Guide

Foundational Papers

Start with Malfait et al. (2017) for EDS classification including collagen types; Loeys et al. (2010) for nosology context; Corsi et al. (2002) for fibril mechanisms.

Recent Advances

Kuivaniemi and Tromp (2019) on COL3A1 details; Tinkle et al. (2017, 454 citations) on hypermobile EDS history.

Core Methods

Genetic sequencing of COL3A1/COL5A1, mouse models of proteoglycan deficiency (Corsi et al., 2002), ascorbic acid assays on matrix formation (Franceschi et al., 1994).

How PapersFlow Helps You Research Ehlers-Danlos Syndrome Collagen Mutations

Discover & Search

Research Agent uses searchPapers and citationGraph on 'COL3A1 mutations vascular EDS' to map 2157-cited Loeys et al. (2010) connections to Malfait et al. (2017). exaSearch uncovers 250M+ OpenAlex papers on COL5A1; findSimilarPapers expands from Kuivaniemi and Tromp (2019).

Analyze & Verify

Analysis Agent applies readPaperContent to extract mutation data from Oderich et al. (2005), then verifyResponse with CoVe checks claims against Corsi et al. (2002). runPythonAnalysis simulates fibril assembly with NumPy on Franceschi et al. (1994) ascorbic acid data; GRADE grades evidence for COL3A1 risks.

Synthesize & Write

Synthesis Agent detects gaps in genotype-phenotype links across Malfait et al. (2017) and Kuivaniemi and Tromp (2019), flags contradictions in fibril models. Writing Agent uses latexEditText and latexSyncCitations for mutation tables, latexCompile for reports, exportMermaid for collagen pathway diagrams.

Use Cases

"Analyze collagen fibril data from biglycan deficiency papers with Python plots"

Research Agent → searchPapers 'biglycan EDS' → Analysis Agent → readPaperContent (Corsi et al. 2002) → runPythonAnalysis (pandas fibril size stats, matplotlib histograms) → researcher gets quantified abnormality metrics.

"Write LaTeX review of COL3A1 mutations in vascular EDS"

Synthesis Agent → gap detection (Malfait 2017 + Kuivaniemi 2019) → Writing Agent → latexEditText (draft sections) → latexSyncCitations (Oderich 2005) → latexCompile → researcher gets compiled PDF with figures.

"Find code for collagen mutation simulation models"

Research Agent → paperExtractUrls (Laurent 2005) → paperFindGithubRepo → githubRepoInspect → researcher gets verified simulation scripts linked to arterial stiffness genetics.

Automated Workflows

Deep Research workflow scans 50+ papers via searchPapers on 'COL3A1 EDS', structures report with GRADE on Malfait et al. (2017). DeepScan's 7-steps verify fibril claims from Corsi et al. (2002) with CoVe checkpoints. Theorizer generates hypotheses on COL5A1 misfolding from Kuivaniemi and Tromp (2019) abstracts.

Try Doxa for Ehlers-Danlos Syndrome Collagen Mutations Research

Frequently Asked Questions

What defines Ehlers-Danlos Syndrome Collagen Mutations?

Genetic variants in COL3A1 and COL5A1 causing vascular and classical EDS via misfolding and matrix defects (Malfait et al., 2017).

What are key methods in this research?

Biophysical modeling of fibril assembly, genotype-phenotype studies, and clinical outcome tracking (Corsi et al., 2002; Oderich et al., 2005).

What are major papers?

Malfait et al. (2017, 1749 citations) on EDS classification; Kuivaniemi and Tromp (2019, 398 citations) on COL3A1; Loeys et al. (2010, 2157 citations) on related nosology.